Traditional and novel approaches to flavivirus vaccines (Q35143285)

6 August 2017

title

Traditional and novel approaches to flavivirus vaccines (English)

1 reference

6 August 2017

4

Thomas P Monath

1 reference

6 August 2017

2

Farshad Guirakhoo

1 reference

6 August 2017

author name string

Konstantin V Pugachev

series ordinal

1

1 reference

6 August 2017

Dennis W Trent

series ordinal

3

1 reference

6 August 2017

publication date

1 May 2003

1 reference

International Journal for Parasitology

6 August 2017

published in

1 reference

6 August 2017

volume

33

1 reference

6 August 2017

issue

5-6

1 reference

6 August 2017

page(s)

567-582

1 reference

Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Development of a novel mouse model for dengue virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Current status of flavivirus vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Construction of intertypic chimeric dengue viruses by substitution of structural protein genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Growth-restricted dengue virus mutants containing deletions in the 5' noncoding region of the RNA genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Recognition of Dengue Virus NS1-NS2a Proteins by Human CD4+ Cytotoxic T Lymphocyte Clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Pathogenesis of dengue: challenges to molecular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Characterization of infectious Murray Valley encephalitis virus derived from a stably cloned genome-length cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Short report: absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Synthesis and characterization of an infectious dengue virus type-2 RNA genome (New Guinea C strain).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Development of new vaccines against dengue fever and Japanese encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Generation and Characterization of a Mammalian Cell Line Continuously Expressing Japanese Encephalitis Virus Subviral Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Sequence of the genes encoding the structural proteins of the low-virulence tick-borne flaviviruses Langat TP21 and Yelantsev

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

A 'minimal' approach in design of flavivirus infectious DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Dengue: the risk to developed and developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

Yellow fever: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Editorial: jennerian vaccination against West Nile virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-hu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

West Nile virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Dengue virus inhibits human hematopoietic progenitor growth in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Positional cloning of the murine flavivirus resistance gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Tick-Borne Langat/Mosquito-Borne Dengue Flavivirus Chimera, a Candidate Live Attenuated Vaccine for Protection against Disease Caused by Members of the Tick-Borne Encephalitis Virus Complex: Evaluation in Rhesus Monkeys and in Mosquitoes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Construction of a full length infectious clone for dengue-1 virus Western Pacific,74 strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Research on dengue during World War II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Defective adenoviruses as novel vaccines for the Flaviviridae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

THE TRANSMISSION OF YELLOW FEVER TO MACACUS RHESUS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Immunization with Heterologous Flaviviruses Protective Against Fatal West Nile Encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Regulation of the late events in flavivirus protein processing and maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

An infectious clone of the West Nile flavivirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF/JE SA14--14--2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

New mouse model for dengue virus vaccine testing

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

Dengue virus structural differences that correlate with pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

Infectious RNA transcripts from full-length dengue virus type 2 cDNA clones made in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900063-8

7 January 2021

10.1016/S0020-7519(03)00063-8

Identifiers

DOI

1 reference

6 August 2017

1 reference